The clinical value of a thorough diagnostic evaluation for neurotologic complaints

Natalie A. Krane, Brian McKinnon, Michelle White, Dani Ashak, Eileen L. Chang, Daniel Park, Sandeep Segar, Jeyanthan Jayakumaran, Clara Grayhack, Robert T. Sataloff

Research output: Contribution to journalArticle

Abstract

Purpose: Determine the clinical efficacy of comprehensive neurotologic testing in patients presenting with complaints of hearing loss, tinnitus and/or dizziness. Methods: This is a retrospective analysis of 1170 consecutive charts of patients who presented between 1980 and 2013 with neurotologic complaints. Demographic data, chief complaint, diagnostic imaging, audiograms, and blood tests were evaluated. Results: Retrospective analysis of 1170 patient charts was performed. 762/1170 (65%) patients presented with subjective hearing loss, 575/1170 (49%) with dizziness, and 657/1170 (56%) with tinnitus. Audiometric testing revealed hearing loss in 1059/1169 (91%) patients. 536/1120 (48%) patients had abnormalities on Magnetic Resonance Imaging, and 343/1087 (32%) on Computed Tomography imaging. Endocrine and immunologic testing revealed 108/1135 (9.5%) patients were hyperglycemic; 125/1124 (11%) patients had elevated TSH; 149/1141 (13%) patients had a positive ANA; and 82/1133 (7.2%) patients were positive for RF. 198/1083 (18%) of patients were positive for HLA-B35, 246/1083 (23%) for HLA-Cw4, 454/1083 (42%) for HLA-Cw7, and 747/1060 (70%) of patients had absent HLA-DR4. 112/1085 (10%) of patients were positive for anti-68kD antibodies and 154/936 (17%) for protein 0. Many patients were diagnosed with previously unrecognized medical conditions. Conclusion: Comprehensive neurotological workup results in diagnoses that would go unrecognized otherwise, allowing patients to receive prompt treatment for medically important conditions, some of which may be causally related to their neurotologic complaints. However, the value of each study for routine testing of patients with neurotologic complaints remains controversial; and the evidence presented herein should help practitioners determine what studies should be included in their patient assessments.

Original languageEnglish (US)
Pages (from-to)16-21
Number of pages6
JournalAmerican Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume40
Issue number1
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Hearing Loss
Tinnitus
Dizziness
HLA-B35 Antigen
HLA-DR4 Antigen
Hematologic Tests
Diagnostic Imaging
Anti-Idiotypic Antibodies
Tomography
Magnetic Resonance Imaging
Demography
Proteins
Therapeutics

Keywords

  • Autoimmune hearing loss
  • Dizziness
  • Hearing loss
  • Neurotology
  • Tinnitus

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

The clinical value of a thorough diagnostic evaluation for neurotologic complaints. / Krane, Natalie A.; McKinnon, Brian; White, Michelle; Ashak, Dani; Chang, Eileen L.; Park, Daniel; Segar, Sandeep; Jayakumaran, Jeyanthan; Grayhack, Clara; Sataloff, Robert T.

In: American Journal of Otolaryngology - Head and Neck Medicine and Surgery, Vol. 40, No. 1, 01.01.2019, p. 16-21.

Research output: Contribution to journalArticle

Krane, NA, McKinnon, B, White, M, Ashak, D, Chang, EL, Park, D, Segar, S, Jayakumaran, J, Grayhack, C & Sataloff, RT 2019, 'The clinical value of a thorough diagnostic evaluation for neurotologic complaints', American Journal of Otolaryngology - Head and Neck Medicine and Surgery, vol. 40, no. 1, pp. 16-21. https://doi.org/10.1016/j.amjoto.2018.09.009
Krane, Natalie A. ; McKinnon, Brian ; White, Michelle ; Ashak, Dani ; Chang, Eileen L. ; Park, Daniel ; Segar, Sandeep ; Jayakumaran, Jeyanthan ; Grayhack, Clara ; Sataloff, Robert T. / The clinical value of a thorough diagnostic evaluation for neurotologic complaints. In: American Journal of Otolaryngology - Head and Neck Medicine and Surgery. 2019 ; Vol. 40, No. 1. pp. 16-21.
@article{e36555b02dd74dfdbe090abc1883a10b,
title = "The clinical value of a thorough diagnostic evaluation for neurotologic complaints",
abstract = "Purpose: Determine the clinical efficacy of comprehensive neurotologic testing in patients presenting with complaints of hearing loss, tinnitus and/or dizziness. Methods: This is a retrospective analysis of 1170 consecutive charts of patients who presented between 1980 and 2013 with neurotologic complaints. Demographic data, chief complaint, diagnostic imaging, audiograms, and blood tests were evaluated. Results: Retrospective analysis of 1170 patient charts was performed. 762/1170 (65{\%}) patients presented with subjective hearing loss, 575/1170 (49{\%}) with dizziness, and 657/1170 (56{\%}) with tinnitus. Audiometric testing revealed hearing loss in 1059/1169 (91{\%}) patients. 536/1120 (48{\%}) patients had abnormalities on Magnetic Resonance Imaging, and 343/1087 (32{\%}) on Computed Tomography imaging. Endocrine and immunologic testing revealed 108/1135 (9.5{\%}) patients were hyperglycemic; 125/1124 (11{\%}) patients had elevated TSH; 149/1141 (13{\%}) patients had a positive ANA; and 82/1133 (7.2{\%}) patients were positive for RF. 198/1083 (18{\%}) of patients were positive for HLA-B35, 246/1083 (23{\%}) for HLA-Cw4, 454/1083 (42{\%}) for HLA-Cw7, and 747/1060 (70{\%}) of patients had absent HLA-DR4. 112/1085 (10{\%}) of patients were positive for anti-68kD antibodies and 154/936 (17{\%}) for protein 0. Many patients were diagnosed with previously unrecognized medical conditions. Conclusion: Comprehensive neurotological workup results in diagnoses that would go unrecognized otherwise, allowing patients to receive prompt treatment for medically important conditions, some of which may be causally related to their neurotologic complaints. However, the value of each study for routine testing of patients with neurotologic complaints remains controversial; and the evidence presented herein should help practitioners determine what studies should be included in their patient assessments.",
keywords = "Autoimmune hearing loss, Dizziness, Hearing loss, Neurotology, Tinnitus",
author = "Krane, {Natalie A.} and Brian McKinnon and Michelle White and Dani Ashak and Chang, {Eileen L.} and Daniel Park and Sandeep Segar and Jeyanthan Jayakumaran and Clara Grayhack and Sataloff, {Robert T.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.amjoto.2018.09.009",
language = "English (US)",
volume = "40",
pages = "16--21",
journal = "American Journal of Otolaryngology - Head and Neck Medicine and Surgery",
issn = "0196-0709",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - The clinical value of a thorough diagnostic evaluation for neurotologic complaints

AU - Krane, Natalie A.

AU - McKinnon, Brian

AU - White, Michelle

AU - Ashak, Dani

AU - Chang, Eileen L.

AU - Park, Daniel

AU - Segar, Sandeep

AU - Jayakumaran, Jeyanthan

AU - Grayhack, Clara

AU - Sataloff, Robert T.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose: Determine the clinical efficacy of comprehensive neurotologic testing in patients presenting with complaints of hearing loss, tinnitus and/or dizziness. Methods: This is a retrospective analysis of 1170 consecutive charts of patients who presented between 1980 and 2013 with neurotologic complaints. Demographic data, chief complaint, diagnostic imaging, audiograms, and blood tests were evaluated. Results: Retrospective analysis of 1170 patient charts was performed. 762/1170 (65%) patients presented with subjective hearing loss, 575/1170 (49%) with dizziness, and 657/1170 (56%) with tinnitus. Audiometric testing revealed hearing loss in 1059/1169 (91%) patients. 536/1120 (48%) patients had abnormalities on Magnetic Resonance Imaging, and 343/1087 (32%) on Computed Tomography imaging. Endocrine and immunologic testing revealed 108/1135 (9.5%) patients were hyperglycemic; 125/1124 (11%) patients had elevated TSH; 149/1141 (13%) patients had a positive ANA; and 82/1133 (7.2%) patients were positive for RF. 198/1083 (18%) of patients were positive for HLA-B35, 246/1083 (23%) for HLA-Cw4, 454/1083 (42%) for HLA-Cw7, and 747/1060 (70%) of patients had absent HLA-DR4. 112/1085 (10%) of patients were positive for anti-68kD antibodies and 154/936 (17%) for protein 0. Many patients were diagnosed with previously unrecognized medical conditions. Conclusion: Comprehensive neurotological workup results in diagnoses that would go unrecognized otherwise, allowing patients to receive prompt treatment for medically important conditions, some of which may be causally related to their neurotologic complaints. However, the value of each study for routine testing of patients with neurotologic complaints remains controversial; and the evidence presented herein should help practitioners determine what studies should be included in their patient assessments.

AB - Purpose: Determine the clinical efficacy of comprehensive neurotologic testing in patients presenting with complaints of hearing loss, tinnitus and/or dizziness. Methods: This is a retrospective analysis of 1170 consecutive charts of patients who presented between 1980 and 2013 with neurotologic complaints. Demographic data, chief complaint, diagnostic imaging, audiograms, and blood tests were evaluated. Results: Retrospective analysis of 1170 patient charts was performed. 762/1170 (65%) patients presented with subjective hearing loss, 575/1170 (49%) with dizziness, and 657/1170 (56%) with tinnitus. Audiometric testing revealed hearing loss in 1059/1169 (91%) patients. 536/1120 (48%) patients had abnormalities on Magnetic Resonance Imaging, and 343/1087 (32%) on Computed Tomography imaging. Endocrine and immunologic testing revealed 108/1135 (9.5%) patients were hyperglycemic; 125/1124 (11%) patients had elevated TSH; 149/1141 (13%) patients had a positive ANA; and 82/1133 (7.2%) patients were positive for RF. 198/1083 (18%) of patients were positive for HLA-B35, 246/1083 (23%) for HLA-Cw4, 454/1083 (42%) for HLA-Cw7, and 747/1060 (70%) of patients had absent HLA-DR4. 112/1085 (10%) of patients were positive for anti-68kD antibodies and 154/936 (17%) for protein 0. Many patients were diagnosed with previously unrecognized medical conditions. Conclusion: Comprehensive neurotological workup results in diagnoses that would go unrecognized otherwise, allowing patients to receive prompt treatment for medically important conditions, some of which may be causally related to their neurotologic complaints. However, the value of each study for routine testing of patients with neurotologic complaints remains controversial; and the evidence presented herein should help practitioners determine what studies should be included in their patient assessments.

KW - Autoimmune hearing loss

KW - Dizziness

KW - Hearing loss

KW - Neurotology

KW - Tinnitus

UR - http://www.scopus.com/inward/record.url?scp=85053687350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053687350&partnerID=8YFLogxK

U2 - 10.1016/j.amjoto.2018.09.009

DO - 10.1016/j.amjoto.2018.09.009

M3 - Article

VL - 40

SP - 16

EP - 21

JO - American Journal of Otolaryngology - Head and Neck Medicine and Surgery

JF - American Journal of Otolaryngology - Head and Neck Medicine and Surgery

SN - 0196-0709

IS - 1

ER -